These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37633775)

  • 1. Association between initial pattern of clozapine titration, concentration-to-dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital.
    Kang N; Kim SH; Kim J; Kim S; Jang J; Yoon H; Lee J; Kim M; Kim YS; Kwon JS
    Schizophr Res; 2024 Jun; 268():131-137. PubMed ID: 37633775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital.
    Kang N; Kim SH; Kim J; Kim S; Jang J; Yoon H; Lee J; Kim M; Kim YS; Kwon JS
    Schizophr Res; 2024 Jun; 268():107-113. PubMed ID: 37770376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research.
    de Leon J
    J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong.
    Pui-yin Chung J; Shiu-yin Chong C; Chung KF; Lai-wah Dunn E; Wai-nang Tang O; Chan WF
    Can J Psychiatry; 2008 Dec; 53(12):857-62. PubMed ID: 19087484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility and Safety of Slower-than-Recommended Titration of Clozapine for Treatment-Resistant Schizophrenia: a Retrospective Cohort Study.
    Tsukahara M; So R; Yada Y; Kodama M; Kishi Y
    Psychiatr Q; 2021 Jun; 92(2):703-713. PubMed ID: 32889690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: A retrospective chart review of seven hospitals.
    Kikuchi Y; Komatsu H; Otsuka Y; Ito F; Kanahara N; Tanifuji H; Tomita H
    Schizophr Res; 2024 Jun; 268():98-106. PubMed ID: 37331881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia.
    Poyraz CA; Özdemir A; Sağlam NG; Turan Ş; Poyraz BÇ; Tomruk N; Duran A
    Psychiatr Q; 2016 Jun; 87(2):315-22. PubMed ID: 26433727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration.
    Carswell O; Wilton LR; Nicholls K; Thomas V; Clark SR
    Schizophr Res; 2024 Jun; 268():88-93. PubMed ID: 37722933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of rapid clozapine titration in schizophrenia.
    Ifteni P; Nielsen J; Burtea V; Correll CU; Kane JM; Manu P
    Acta Psychiatr Scand; 2014 Jul; 130(1):25-9. PubMed ID: 24354448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; Wolfe R; McNeil JJ
    Schizophr Res; 2012 Nov; 141(2-3):173-8. PubMed ID: 23010488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A target-dose finding study of clozapine in patients with schizophrenia.
    Bennett JA; Keck PE
    Ann Clin Psychiatry; 1996 Mar; 8(1):19-21. PubMed ID: 8743644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.
    de Leon J; Ruan CJ; Schoretsanitis G; De Las Cuevas C
    Psychother Psychosom; 2020; 89(4):200-214. PubMed ID: 32289791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine dose for schizophrenia.
    Subramanian S; Völlm BA; Huband N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009555. PubMed ID: 28613395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
    Kikuchi Y; Komatsu H; Otsuka Y; Ito F; Yada Y; Tanifuji H; Tomita H
    Psychiatry Res; 2024 Apr; 334():115810. PubMed ID: 38382186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.
    Kim Y; Kim BN; Cho SC; Kim JW; Shin MS
    Hum Psychopharmacol; 2008 Dec; 23(8):715-22. PubMed ID: 18814190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid clozapine titration in treatment-refractory bipolar disorder.
    Ifteni P; Correll CU; Nielsen J; Burtea V; Kane JM; Manu P
    J Affect Disord; 2014 Sep; 166():168-72. PubMed ID: 25012427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Management of Clozapine-Induced Myocarditis in a Large Tertiary Hospital.
    Higgins JM; San C; Lagnado G; Chua D; Mihic T
    Can J Psychiatry; 2019 Aug; 64(8):561-567. PubMed ID: 30599763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.
    Szota A; Ogłodek E; Araszkiewicz A
    Pharmacol Rep; 2013; 65(2):279-87. PubMed ID: 23744413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report.
    Gerasimou C; Vitali GP; Vavougios GD; Papageorgiou C; Douzenis A; Kokoris SI; Liappas I; Rizos E
    In Vivo; 2017 Jan; 31(1):141-143. PubMed ID: 28064233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.